See how top analysts and institutions rate BAC — including buy, hold, and sell recommendations.
| Rating Source | Action | Rating | Target Price | Updated |
|---|---|---|---|---|
| Erste Group | Upgrade | Hold → Buy | 2025-10-03 | |
| HSBC Securities | Downgrade | Buy → Hold | $51 | 2025-07-08 |
| Robert W. Baird | Downgrade | Outperform → Neutral | $52 | 2025-06-27 |
| TD Cowen | Initiated | Buy | $53 | 2025-05-15 |
| Date | Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|---|
| November 2025 | 7 | 14 | 3 | 0 | 1 |
| October 2025 | 7 | 14 | 3 | 0 | 1 |
| September 2025 | 7 | 14 | 3 | 0 | 1 |
| August 2025 | 7 | 14 | 4 | 0 | 0 |
The majority of institutional investors have issued a "Buy" rating for BAC, and analyst sentiment aligns closely, with very few "Sell" recommendations. This suggests a broadly favorable outlook for the stock's performance.
